Literature DB >> 29288210

Switching from the bio-originators to biosimilar: is it premature to recommend this procedure?

Fabrizio Cantini1, Maurizio Benucci2.   

Abstract

Keywords:  ankylosing spondylitis; anti-tnf; psoriatic arthritis; rheumatoid arthritis; treatment

Mesh：

Substances：

Year:  2017        PMID： 29288210     DOI： 10.1136/annrheumdis-2017-212820

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Focus on biosimilar etanercept - bioequivalence and interchangeability.

Authors:  Fabrizio Cantini; Maurizio Benucci
Journal:  Biologics       Date:  2018-08-30

2.  Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs? A Danish register-based study of patients with inflammatory arthritis.

Authors:  Bente Glintborg; Rikke Ibsen; Rebecca Elisabeth Qwist Bilbo; Merete Lund Hetland; Jakob Kjellberg
Journal:  RMD Open       Date:  2019-08-12

Review 3.  Tendering and biosimilars: what role for value-added services?

Authors:  Steven Simoens; Raymond Cheung
Journal:  J Mark Access Health Policy       Date:  2019-12-22

4.  Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018.

Authors:  Yifei Liu; Martha Skup; Min Yang; Cynthia Z Qi; Eric Q Wu
Journal:  Adv Ther       Date:  2022-06-23       Impact factor: 4.070

Review 5.  An Update Review of Biosimilars of Adalimumab in Psoriasis - Bioequivalence and Interchangeability.

Authors:  Xin Zhou; Zhuo Chen; Xinling Bi
Journal:  Drug Des Devel Ther       Date:  2021-07-08       Impact factor: 4.162

6.  Does a mandatory non-medical switch from originator to biosimilar infliximab lead to increased use of outpatient healthcare resources? A register-based study in patients with inflammatory arthritis.

Authors:  Bente Glintborg; Jan Sørensen; Merete Lund Hetland
Journal:  RMD Open       Date:  2018-07-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.